Verity Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,267
| Closed | -$311K | – | 135 |
|
|
2019
Q3 | $311K | Buy |
7,267
+74
| +1% | +$3.17K | 0.33% | 93 |
|
|
2019
Q2 | $457K | Sell |
7,193
-943
| -12% | -$59.9K | 0.51% | 66 |
|
|
2019
Q1 | $564K | Buy |
8,136
+555
| +7% | +$38.5K | 0.65% | 41 |
|
|
2018
Q4 | $330K | Buy |
7,581
+2,011
| +36% | +$87.5K | 0.44% | 62 |
|
|
2018
Q3 | $425K | Buy |
5,570
+559
| +11% | +$42.7K | 0.42% | 53 |
|
|
2018
Q2 | $385K | Sell |
5,011
-2,234
| -31% | -$172K | 0.35% | 56 |
|
|
2018
Q1 | $369K | Buy |
7,245
+1,512
| +26% | +$77K | 0.34% | 53 |
|
|
2017
Q4 | $306K | Buy |
+5,733
| New | +$306K | 0.23% | 80 |
|